Carcinoma, Non-Small-Cell Lung Clinical Trials

A listing of 47 Carcinoma, Non-Small-Cell Lung clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Carcinoma, Non-Small-Cell Lung

1 - 12 of 47

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 47 active clinical trials seeking participants for Carcinoma, Non-Small-Cell Lung research studies. The states with the highest number of trials for Autism participants are California, Florida, Texas and New York.

Featured Trial

Major Depressive Disorder Clinical Study

Recruiting

Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.

Conditions:

Major Depressive Disorder

Major Depression

Major Depressive Episode

Major Depressive Disorder (MDD)

Major Depressive Disorders

Learn More

Featured Trial

Hyperacusis Activities Treatment-Online Study

Recruiting

Are you experiencing hyperacusis? If so, we are recruiting adults with hyperacusis to complete a clinical trial supported by the National Institutes of Health. The study involves participating in a remote counseling program and sound therapy trial for hyperacusis, Hyperacusis Activities Treatment-Online.

Conditions:

Hyperacusis

Tinnitus

Hearing Loss

Learn More

A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer

NCT05068024

Recruiting

The purpose of this study is to characterize the safety and tolerability of FWD1509 MsOH in advanced NSCLC patients and establish the maximum tolerable dose (MTD), recommended phase 2 dose (RP2D) in advanced NSCLC patients.

Gender:

All

Ages:

18 years and above

Trial Updated:

07/20/2022

Locations: Gabrail Cancer Center, Canton, Ohio +1 locations

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

NCT06140836

Recruiting

The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC).

Gender:

All

Ages:

18 years and above

Trial Updated:

05/02/2024

Locations: Local Institution - 0136, Augusta, Georgia +134 locations

Local Institution - 0136, Augusta, Georgia

Local Institution - 0075, Boston, Massachusetts

Local Institution - 0201, Boston, Massachusetts

Local Institution - 0217, Brooklyn, New York

Local Institution - 0210, Mineola, New York

Laura and Isaac Perlmutter Cancer Center, New York, New York

Local Institution - 0127, Syracuse, New York

Local Institution - 0061, Milwaukee, Wisconsin

Hospital Británico de Buenos Aires, Ciudad autónoma de Buenos Aires, Buenos Aires

Local Institution - 0090, Ciudad Autónoma de Buenos Aires, Buenos Aires

Local Institution - 0091, ABB, Ciudad Autónoma De Buenos Aires

Local Institution - 0106, Buenos Aires, Not set

Local Institution - 0207, Buenos Aires, Not set

Instituto Oncológico de Córdoba, Córdoba, Not set

Klinik Floridsdorf, Wien, Not set

Hospital Luxemburgo, Belo Horizonte, Minas Gerais

Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, Rio Grande Do Sul

Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo

Local Institution - 0209, Sao Paulo, São Paulo

Hospital Paulistano, Sao Paulo, São Paulo

Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo

Local Institution - 0098, Rio de Janeiro, Not set

Local Institution - 0108, Rio de Janeiro, Not set

Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Not set

Local Institution - 0114, São Paulo, Not set

Princess Margaret Cancer Centre, Toronto, Ontario

Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec, Trois-Rivières, Quebec

Local Institution - 0094, Santiago, Región Metropolitana De Santiago

Local Institution - 0096, Viña del Mar, Valparaíso

Beijing Cancer Hospital, Beijing, Beijing

Army Medical Center of PLA, Chongqing, Chongqing

Local Institution - 0192, Fuzhou, Fujian

Local Institution - 0169, Xiamen, Fujian

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi

Local Institution - 0171, Harbin, Heilongjiang

Henan Cancer Hospital, Zhengzhou, Henan

Hubei Cancer Hospital, Wuhan Shi, Hubei

Local Institution - 0203, Wuhan, Hubei

Hunan Province People'S Hospital, Changsha, Hunan

Local Institution - 0165, Changsha, Hunan

Jiangsu Province Hospital Of Chinese Medicine, Nanjing, Jiangsu

Local Institution - 0202, Nanchang, Jiangxi

Jilin Cancer Hospital, Changchun, Jilin

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi

Shandong Cancer Hospital, Jinan, Shandong

Local Institution - 0205, Linyi, Shandong

Shanghai Chest Hospital, Shanghai, Shanghai

Local Institution - 0179, Shanghai, Shanghai

Local Institution - 0170, Chengdu, Sichuan

Local Institution - 0177, Chengdu, Sichuan

Local Institution - 0204, Kunming, Yunnan

Local Institution - 0206, Hangzhou, Zhejiang

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Nouvel Hôpital Civil (NHC), Strasbourg, Alsace

CHU Bordeaux Haut-Leveque, Pessac, Aquitaine

Local Institution - 0109, Dijon, Côte-d'Or

Hopital Charles Nicolle C H U Rouen, Rouen, Haute-Normandie

Chu Grenoble Alpes, La Tronche, Isère

Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes, Saint-Herblain, Loire-Atlantique

Centre Hospitalier Lyon Sud, Pierre-Bénite, Rhône

Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set

Klinikum Esslingen, Esslingen, Baden-Württemberg

Klinikum Würzburg Mitte, Wuerzburg, Bayern

Pius Hospital Oldenburg, Oldenburg, Niedersachsen

Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Sachsen

Evangelische Lungenklinik Berlin, Berlin, Not set

Asklepios Klinik Gauting GmbH, Gauting, Not set

Lungenfachklinik Immenhausen, Immenhausen, Not set

Universitaetsklinikum Koeln, Köln, Not set

Marienhaus Klinikum Mainz, Mainz, Not set

University Hospital of Patras, Patras, Achaḯa

Local Institution - 0153, Athens, Attikí

Attikon General University Hospital, Chaidari, Attikí

Local Institution - 0156, Thessaloniki, Kentrikí Makedonía

Local Institution - 0135, Budapest, Not set

Local Institution - 0076, New Delhi, Delhi

Local Institution - 0102, Ahmedabad, Gujarat

Local Institution - 0118, Ahmedabad, Gujarat

Local Institution - 0117, Gurgaon, Haryana

Local Institution - 0044, Gurugram, Haryana

Local Institution - 0082, Bengaluru, Karnataka

Local Institution - 0065, Mumbai, Maharashtra

Local Institution - 0048, Mumbai, Maharashtra

Local Institution - 0045, Pune, Maharashtra

Local Institution - 0049, Pune, Maharashtra

Local Institution - 0220, Hyderabad, Telangana

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia

Fondazione IRCCS San Gerardo dei Tintori, Monza, Lombardia

A.O.R.N. Ospedale dei Colli - Monaldi V., Naples, Napoli

Istituto Nazionale Tumori Regina Elena, Rome, Roma

Local Institution - 0151, Aviano, Not set

Nagoya University Hospital, Nagoya, Aichi

National Cancer Center Hospital East, Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime

Hokkaido University Hospital, Sapporo, Hokkaido

Kanagawa cancer center, Yokohama, Kanagawa

Sendai Kousei Hospital, Sendai, Miyagi

Local Institution - 0198, Bunkyo ku, Tokyo

Tottori University Hospital, Yonago, Tottori

National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set

Osaka City General Hospital, Osaka, Not set

Osaka International Cancer Institute, Osaka, Not set

Tokyo Metropolitan Police Hospital, Tokyo, Not set

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]

Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do

Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]

Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0216, Amsterdam, Noord-Holland

Local Institution - 0215, Groningen, Not set

Instytut Genetyki i Immunologii GENIM, Lublin, Lubelskie

Local Institution - 0196, Olsztyn, Warmińsko-mazurskie

Institutul Oncologic Bucuresti, Bucharest, București

Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj

Centrul medical Focus, București, Not set

Institutul Oncologic Cluj, Cluj, Not set

S.C. Centrul de Oncologie Euroclinic S.R.L., Iași, Not set

CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [La Coruña]

CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]

Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De

Local Institution - 0139, Majadahonda, Madrid, Comunidad De

H.R.U Málaga - Hospital General, Málaga, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Hospital Universitari i Politecnic La Fe, València, Not set

Kantonspital Baden, Baden, Not set

Local Institution - 0086, Yenimahalle, Ankara

Local Institution - 0087, Stanbul, İstanbul

Local Institution - 0088, Adana, Not set

Local Institution - 0084, Ankara, Not set

Local Institution - 0097, Istanbul, Not set

Local Institution - 0083, Istanbul, Not set

Local Institution - 0085, Sakarya, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

NCT04956640

Recruiting

The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific genetic mutation (KRAS G12C). Patients must have already received or were not able to tolerate the standard of care, except for specific groups who have not had cancer treatment. The study will last up to approximately 4 years.

Gender:

All

Ages:

18 years and above

Trial Updated:

05/02/2024

Locations: University of Alabama at Birmingham, Birmingham, Alabama +49 locations

University of Alabama at Birmingham, Birmingham, Alabama

USC Norris Cancer Hospital, Los Angeles, California

Chao Family Comprehensive Cancer Ctr., Orange, California

Yale-New Haven Hospital, New Haven, Connecticut

AdventHealth Orlando, Orlando, Florida

Florida Cancer Specialists, Sarasota, Florida

Indiana Univ Melvin & Bren Simon Cancer Center, Indianapolis, Indiana

Community Health Network, Indianapolis, Indiana

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

Massachusetts General Hospital, Boston, Massachusetts

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

NYU Langone Health- Long Island, Mineola, New York

NYU Langone, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Novant Health Cancer Institute - Elizabeth, Charlotte, North Carolina

Novant Health Cancer Institute - Forsyth, Winston-Salem, North Carolina

Fox Chase Cancer Center, Philadelphia, Pennsylvania

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania

Sarah Cannon Cancer Center, Nashville, Tennessee

Vanderbilt Univeristy School of Medicine, Nashville, Tennessee

South Texas Accelerated Research Therapeutics (START), San Antonio, Texas

START Mountain Region, West Valley City, Utah

Inova Health System IRB, Fairfax, Virginia

USO-Virginia Cancer Specialists, PC, Fairfax, Virginia

University of Wisconsin-Madison Hospital and Health Clinic, Madison, Wisconsin

Royal North Shore Hospital, St Leonards, New South Wales

St Vincent's Hospital Sydney, Sydney, New South Wales

Cancer Research SA, Adelaide, South Australia

Peninsula and Southeast Oncology, Frankston, Victoria

Linear Clinical Research, Nedlands, Western Australia

Cross Cancer Institute, Edmonton, Alberta

Princess Margaret Hospital (Ontario), Toronto, Ontario

Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, Aquitaine

Centre Leon Berard, Lyon, Rhône-Alpes

Institut du Cancer de Montpellier - Val d'aurelle, Montpellier Cedex 5, Not set

Institut Curie, Paris CEDEX 05, Not set

Institut Claudius Regaud - IUCT Oncopole, Toulouse cedex, Not set

Gustave Roussy, Villejuif Cedex, Not set

Aichi Cancer Center Hospital, Nagoya, Aichi

National Cancer Center Hospital East, Kashiwa, Chiba

Hokkaido University Hospital, Sapporo, Hokkaido

Kanazawa University Hospital, Kanazawa-shi, Ishikawa

National Cancer Center Hospital, Chuo-ku, Tokyo

Wakayama Medical University Hospital, Wakayama, Not set

National Cancer Center, Goyang-si, Gyeonggi-do

The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Gyeonggi-do

Chonnam National University Hwasun Hospital, Hwasun-gun, Jeonranamdo

Seoul National University Hospital, Seoul, Korea

Asan Medical Center, Seoul, Korea

Conditions: Carcinoma, Non-Small-Cell Lung, Endometrial Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Biliary Tract Neoplasms, Colorectal Neoplasms

Learn More ›

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

NCT05642195

Recruiting

Background: Surgery is the primary treatment for non-small cell lung cancer (NSCLC) that is diagnosed in its earlier stages. But the tumors often return. Radiation and chemotherapy can improve survival in some people who have had surgery for NSCLC, but these treatments also cause serious side effects. A new approach, called immunotherapy, may be a better way to stop NSCLC tumors from coming back. Objective: To test a new treatment (H1299 lung cancer cell vaccine combined with the drug N-803)... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

05/02/2024

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinomas

Learn More ›

A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)

NCT03337698

Recruiting

This study will evaluate the efficacy, safety, and pharmacokinetics of immunotherapy-based treatment combinations in participants with metastatic non-small cell lung cancer (NSCLC). Two cohorts will be enrolled in parallel in this study: Cohort 1 will consist of participants with tumor PD-L1 expression who have received no prior systemic therapy for metastatic NSCLC, and Cohort 2 will consist of participants who experienced disease progression during or following treatment with a platinum-conta... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

05/01/2024

Locations: Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut +37 locations

Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut

Christiana Care Health Services, Newark, Delaware

Massachusetts General Hospital, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley, Las Vegas, Nevada

Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749, New York, New York

University Hospitals Case Medical Center; Seidman Cancer Center, Cleveland, Ohio

Cleveland Clinic, Cleveland, Ohio

SCRI Oncology Partners, Nashville, Tennessee

Blacktown Hospital, Blacktown, New South Wales

Peter Mac Callum Cancer Center, East Melbourne, Victoria

CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre, Bordeaux, Not set

Centre Georges Francois Leclerc, Dijon, Not set

Centre Léon Bérard, Lyon, Not set

Hopital de la Timone, Marseille, Not set

Institut Régional du Cancer de Montpellier, Montpellier, Not set

Institut De Cancerologie De L'Ouest; Medical Oncology, Saint Herblain, Not set

Institut Universitaire du Cancer de Toulouse-Oncopole; PHARMACIE, Toulouse, Not set

Rambam Medical Center; Oncology, Haifa, Not set

Rabin Medical Center, Petach Tikva, Not set

Chaim Sheba Medical Center; Oncology Dept, Ramat Gan, Not set

Chonnam National University Hwasun Hospital, Jeollanam-do, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Korea University Guro Hospital, Seoul, Not set

University of Ulsan College of Medicine - Asan Medical Center (AMC) - Asan Cancer Center (ACC), Songpa-gu, Not set

Clínica Universidad de Navarra, Pamplona, Navarra

Hospital Universitari Vall d'Hebron, Barcelona, Not set

Hospital Universitario La Paz, Madrid, Not set

Fundación Jimenez Díaz, Madrid, Not set

Hospital Universitario HM Sanchinarro-CIOCC, Madrid, Not set

Hospital Regional Universitario de Malaga, Malaga, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

National Cheng Kung University Hospital; Gasterointestinal, Tainan City, Not set

Taipei Veterans General Hospital, Taipei City, Not set

Barts Cancer Institute, London, Not set

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Not set

Royal Marsden Hospital; Institute of Cancer Research, Sutton, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

NCT04699188

Recruiting

This is a phase Ib/II open label study. The escalation part will characterize the safety and tolerability of JDQ443 single agent and JDQ443 in combination with the other study treatments (TNO155 and tislelizumab) in advanced solid tumor patients. After the determination of the maximum tolerated dose / recommended dose for a particular treatment arm, dose expansion will assess the anti-tumor activity and further assess the safety, tolerability, and PK/PD of each regimen at the maximum tolerated d... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

04/30/2024

Locations: Emory University School of Medicine/Winship Cancer Institute Winship Cancer Center, Atlanta, Georgia +43 locations

Emory University School of Medicine/Winship Cancer Institute Winship Cancer Center, Atlanta, Georgia

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Washington Uni School of Med ., Saint Louis, Missouri

Providence Cancer Center, Portland, Oregon

Hillman Cancer Center, Pittsburgh, Pennsylvania

Uni of TX MD Anderson Cancer Cntr Dept of MD Anderson CancerCent, Houston, Texas

Novartis Investigative Site, Melbourne, Victoria

Novartis Investigative Site, Leuven, Not set

Novartis Investigative Site, Montreal, Quebec

Novartis Investigative Site, Fuzhou, Fujian

Novartis Investigative Site, Guangzhou, Guangdong

Novartis Investigative Site, Nanchang, Jiangxi

Novartis Investigative Site, Beijing, Not set

Novartis Investigative Site, Copenhagen, Not set

Novartis Investigative Site, Lyon, Not set

Novartis Investigative Site, Marseille, Not set

Novartis Investigative Site, Villejuif, Not set

Novartis Investigative Site, Dresden, Not set

Novartis Investigative Site, Essen, Not set

Novartis Investigative Site, Freiburg, Not set

Novartis Investigative Site, Koeln, Not set

Novartis Investigative Site, Hong Kong, Not set

Novartis Investigative Site, Brescia, BS

Novartis Investigative Site, Milano, MI

Novartis Investigative Site, Nagoya, Aichi

Novartis Investigative Site, Kashiwa, Chiba

Novartis Investigative Site, Yokohama-city, Kanagawa

Novartis Investigative Site, Osaka-city, Osaka

Novartis Investigative Site, Chuo ku, Tokyo

Novartis Investigative Site, Koto ku, Tokyo

Novartis Investigative Site, Osaka, Not set

Novartis Investigative Site, Seoul, Not set

Novartis Investigative Site, Amsterdam, Not set

Novartis Investigative Site, Singapore, Not set

Novartis Investigative Site, Malaga, Andalucia

Novartis Investigative Site, Barcelona, Catalunya

Novartis Investigative Site, Hospitalet de LLobregat, Catalunya

Novartis Investigative Site, Valencia, Comunidad Valenciana

Novartis Investigative Site, Santiago De Compostela, Galicia

Novartis Investigative Site, Madrid, Not set

Novartis Investigative Site, Tainan, Not set

Novartis Investigative Site, Taipei, Not set

Conditions: KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung, Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary, Pulmonary Cancer, Pulmonary Neoplasms

Learn More ›

A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer

NCT04931654

Recruiting

This is a Phase I/IIa study designed to evaluate if experimental anti-PD-1 and anti-TIM-3 bispecific antibody, AZD7789 is safe, tolerable and efficacious in participants with advanced solid tumors.

Gender:

All

Ages:

Between 18 years and 130 years

Trial Updated:

04/26/2024

Locations: Research Site, Atlanta, Georgia +26 locations

Conditions: Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer

Learn More ›

A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients

NCT06008093

Recruiting

The purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy in metastatic NSCLC patients with non-squamous histology who have mutations and/or co-mutations in STK11, KEAP1, or KRAS.

Gender:

All

Ages:

Between 18 years and 130 years

Trial Updated:

04/26/2024

Locations: Research Site, Birmingham, Alabama +63 locations

Research Site, Birmingham, Alabama

Research Site, Anchorage, Alaska

Research Site, Chandler, Arizona

Research Site, Irvine, California

Research Site, La Jolla, California

Research Site, Loma Linda, California

Research Site, Los Angeles, California

Research Site, Santa Monica, California

Research Site, Washington, District of Columbia

Research Site, Fort Lauderdale, Florida

Research Site, Jupiter, Florida

Research Site, Ocala, Florida

Research Site, Orlando, Florida

Research Site, Tampa, Florida

Research Site, Albany, Georgia

Research Site, Atlanta, Georgia

Research Site, Columbus, Georgia

Research Site, Chicago, Illinois

Research Site, Maywood, Illinois

Research Site, Urbana, Illinois

Research Site, Evansville, Indiana

Research Site, Westwood, Kansas

Research Site, Lexington, Kentucky

Research Site, Bethesda, Maryland

Research Site, Worcester, Massachusetts

Research Site, Detroit, Michigan

Research Site, Farmington Hills, Michigan

Research Site, Saint Paul, Minnesota

Research Site, Kansas City, Missouri

Research Site, Saint Louis, Missouri

Research Site, Billings, Montana

Research Site, Albany, New York

Research Site, Bronx, New York

Research Site, New Hyde Park, New York

Research Site, New York, New York

Research Site, Northport, New York

Research Site, Shirley, New York

Research Site, Stony Brook, New York

Research Site, Bismarck, North Dakota

Research Site, Cleveland, Ohio

Research Site, Columbus, Ohio

Research Site, Dayton, Ohio

Research Site, Toledo, Ohio

Research Site, Oklahoma City, Oklahoma

Research Site, Hershey, Pennsylvania

Research Site, Philadelphia, Pennsylvania

Research Site, Providence, Rhode Island

Research Site, Memphis, Tennessee

Research Site, Nashville, Tennessee

Research Site, Austin, Texas

Research Site, Dallas, Texas

Research Site, Fort Worth, Texas

Research Site, Houston, Texas

Research Site, San Antonio, Texas

Research Site, Charlottesville, Virginia

Research Site, Fairfax, Virginia

Research Site, Richmond, Virginia

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

A Study of LY3537982 Plus Immunotherapy With or Without Chemotherapy in Participants With Non-Small Cell Lung Cancer (NSCLC) With a Change in a Gene Called KRAS G12C

NCT06119581

Recruiting

The purpose of this study is to assess if adding LY3537982 in combination with standard of care anti-cancer drugs is more effective than standard of care in participants with untreated advanced NSCLC. NSCLC must have a change in a gene called KRAS G12C. Study participation, including follow-up, could last up to 3 years, depending on how you and your lung cancer are doing.

Gender:

All

Ages:

18 years and above

Trial Updated:

04/25/2024

Locations: Clearview Cancer Institute, Huntsville, Alabama +364 locations

Clearview Cancer Institute, Huntsville, Alabama

The University of Arizona Cancer Center - North Campus, Tucson, Arizona

Mercy UC Davis Cancer Center, Merced, California

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California

Yale University School of Medicine, New Haven, Connecticut

Sibley Memorial Hospital, Washington, District of Columbia

Millennium Oncology - Hollywood, Hollywood, Florida

Miami Cancer Institute at Baptist Health, Inc., Miami, Florida

Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala, Florida

Comprehensive Hematology Oncology, Saint Petersburg, Florida

Tampa General Hospital, Tampa, Florida

University of Illinois at Chicago, Chicago, Illinois

University of Chicago Hospital, Chicago, Illinois

Springfield Clinic Main Campus, Springfield, Illinois

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana

Community Cancer Center North, Indianapolis, Indiana

The University of Kansas Cancer Center - Westwood, Westwood, Kansas

University of Kentucky Chandler Medical Center, Lexington, Kentucky

Johns Hopkins Bayview Medical Center, Baltimore, Maryland

Boston Medical Center, Boston, Massachusetts

Lahey Hospital & Medical Center, Burlington, Massachusetts

University of Michigan, Ann Arbor, Michigan

Karmanos Cancer Institute, Detroit, Michigan

Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan

Allina Health Cancer Institute, Minneapolis, Minnesota

HealthPartners Cancer Research Center, Saint Paul, Minnesota

Saint Louis University Cancer Center, Saint Louis, Missouri

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Summit Health, Florham Park, New Jersey

The Valley Hospital, Paramus, New Jersey

Capital Health Medical Center - Hopewell, Pennington, New Jersey

University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico

Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York

Laura and Isaac Perlmutter Cancer Center, New York, New York

Manhattan Eye, Ear and Throat Hospital, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Clinical Research Alliance, Westbury, New York

University of North Carolina Medical Center, Chapel Hill, North Carolina

Duke Cancer Institute, Durham, North Carolina

UNC REX Cancer Center, Raleigh, North Carolina

University of Oklahoma Health Sciences Center, Peggy and Charles Stephenson Oklahoma Cancer Center, Oklahoma City, Oklahoma

Asante Rogue Regional Medical Center, Medford, Oregon

Providence Portland Medical Center, Portland, Oregon

Providence St. Vincent Medical Center, Portland, Oregon

Kaiser Permanente Interstate Medical Office Central, Portland, Oregon

Bryn Mawr Hospital, Bryn Mawr, Pennsylvania

Paoli Memorial Hospital, Paoli, Pennsylvania

Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia, Pennsylvania

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania

Lankenau Medical Center, Wynnewood, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

Tidelands Health Oncology, Murrells Inlet, South Carolina

Baptist Memorial Hospital-Memphis, Memphis, Tennessee

William Beaumont Army Medical Center, Fort Bliss, Texas

Brooke Army Medical Center, Fort Sam Houston, Texas

Houston Methodist Hospital, Houston, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Baylor Scott & White Medical Center - Temple, Temple, Texas

Swedish Medical Center, Seattle, Washington

Gosford Hospital, Gosford, New South Wales

Icon Cancer Centre Wesley, Auchenflower, Queensland

Sunshine Coast University Hospital, Birtinya, Queensland

Mackay Base Hospital, Mackay, Queensland

Gold Coast University Hospital, Southport, Queensland

The Townsville Hospital, Townsville, Queensland

Royal Adelaide Hospital, Adelaide, South Australia

Ballarat Health Services, Ballarat Central, Victoria

St Vincent's Hospital, Melbourne, Victoria

Goulburn Valley Health, Shepparton, Victoria

Sir Charles Gairdner Hospital, Perth, Western Australia

Ordensklinikum Linz GmbH Elisabethinen, Linz, Oberösterreich

Landeskrankenhaus Feldkirch, Feldkirch, Vorarlberg

ZNA Middelheim, Antwerp, Antwerpen

AZ Sint-Maarten, Campus Leopoldstraat 2, Mechelen, Antwerpen

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godinne, Yvoir, Namur

UZ Gent, Gent, Oost-Vlaanderen

UZ Leuven, Leuven, Vlaams-Brabant

AZ Sint-Jan Brugge-Oostende AV, Brugge, West-Vlaanderen

AZ Groeninge Campus Kennedylaan, Kortrijk, West-Vlaanderen

Clinique Saint Pierre, Ottignies, Not set

AZ Glorieux Ronse, Ronse, Not set

Clinica Amo - Rio Vermelho, Salvador, Bahia

Centro de Pesquisa Clínica do Instituto do Câncer do Ceará, Fortaleza, Ceará

Sirio-Libanes Brasilia - Centro de Oncologia - Asa Sul, Brasilia, Distrito Federal

Hospital Brasilia, Lago sul, Distrito Federal

Hospital São Domingos, Bequimao, Maranhão

Oncominas, Pouso Alegre, Minas Gerais

Hospital Universitário Evangélico Mackenzie, Curitiba, Parana

Hospital de Cancer de Londrina, Londrina, Paraná

Liga Norte Riograndense Contra o Câncer, Natal, Rio Grande Do Norte

Hospital Tacchini, Bento Gonçalves, Rio Grande Do Sul

ONCOSITE - Centro de Pesquisa Clinica em Oncologia, Ijui, Rio Grande Do Sul

Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul

Faculdade de Medicina do ABC, Santo André, São Paulo

Hospital BP, Sao Paulo, São Paulo

Hospital Paulistano, Sao Paulo, São Paulo

Instituto D'Or de Pesquisa e Ensino (IDOR), Sao Paulo, São Paulo

COE Ensino e Pesquisa, São José dos Campos, São Paulo

Instituto Nacional de Câncer - INCA, Rio de Janeiro, Not set

Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA, Rio de Janeiro, Not set

Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo, Not set

Hospital Sírio Libanês, São Paulo, Not set

Centro Paulista de Oncologia Clínica, São Paulo, Not set

Núcleo de Pesquisa Clínica da Rede São Camilo, São Paulo, Not set

Instituto de Assist├ncia M├dica ao Servidor P, São Paulo, Not set

BC Cancer Vancouver, Vancouver, British Columbia

CIUSSS- saguenay-Lac-Saint-Jean, Chicoutimi, Quebec

Unité de Recherche Clinique du CISSS des Laurentides, Saint-Jérôme, Quebec

Wannan Medical College Yijishan Hospital, Wuhu, Anhui

Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing

Beijing Cancer hospital, Beijing, Beijing

The First Affiliated Hospital of the Third Military Medical University, Shapingba, Chongqing

Fujian Provincial Cancer Hospital, Fuzhou, Fujian

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong

Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong

Liuzhou People's Hospital, Liuzhou, Guangxi

Hainan General Hospital, Haikou, Hainan

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan

Wuhan Union Hospital, Wuhan, Hubei

Tongji Hospital Tongji Medical,Science & Technology, Wuhan, Hubei

Renmin Hospital of Wuhan University, Wuhan, Hubei

Xiangyang Central Hospital, Xiangyang, Hubei

Hunan Cancer Hospital, Changsha, Hunan

ZhuZhou Central Hospital, Zhuzhou, Hunan

The First People's Hospital of Changzhou, Changzhou, Jiangsu

Nanjing First Hospital, Nanjing, Jiangsu

Jiangsu Province Hospital, Nanjing, Jiangsu

Nantong Tumor Hospital, Nantong, Jiangsu

The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi

Jilin Cancer Hospital, Changchun, Jilin

Tangdu Hospital of Fourth Military Medical University of Chinese People's Liberation Army, Xi'an, Shaanxi

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi

Jinan Central Hospital, Jinan, Shandong

Shandong Cancer Hospital, Jinan, Shandong

LinYi Cancer Hospital, Linyi, Shandong

Shanghai Chest Hospital, Shanghai, Shanghai

The Third People's Hospital of Chengdu (CDTPH), Chengdu, Sichuan

West China Hospital, Sichuan University, ChengDu, Sichuan

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin

The First Affiliated Hospital of Xinjiang Medical University, Urumchi, Xinjiang

The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang

Sir Run Run Shaw Hospital, Hangzhou, Zhejiang

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang

Hwa Mei Hospital University of Chinese Academy of Sciences, Ningbo, Zhejiang

Sichuan Cancer hospital, Chengdu, Not set

Yichang Central People's Hospital, Yichang, Not set

Nemocnice AGEL Ostrava - Vitkovice a.s., Ostrava, Ostrava Mě

Fakultni nemocnice Bulovka, Prague, Praha 8

Næstved Sygehus, Næstved, Sjælland

Roskilde University Hospital, Roskilde, Sjælland

Centre Antoine-Lacassagne, Nice, Alpes-Maritimes

Nouvel Hôpital Civil (NHC), Strasbourg, Alsace

CHU Bordeaux Haut-Leveque, Pessac, Aquitaine

CHU de Toulouse - Hopital Larrey, Toulouse, Haute-Garonne

Hôpital Foch, Suresnes, Hauts-de-Seine

Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou, Rennes, Ille-et-Vilaine

Centre de Cancérologie du Grand Montpellier, Montpellier, Languedoc-Roussillon

Institut de Cancérologie de l'Ouest, Saint Herblain, Loire-Atlantique

Hôpital Robert Schuman, Vantoux, Lorraine

Institut Jean Godinot, Reims, Marne

CHU Lille - Institut Coeur Poumon, Lille Cedex, Nord

Centre Hospitalier intercommunal de Toulon La Seyne sur Mer, Toulon, Provence-Alpes-Côte-d'Azur

Centre Leon Berard, Lyon, Rhône-Alpes

Hospices Civils de Lyon - Hopital Louis Pradel, Bron, Rhône

Gustave Roussy, Villejuif, Val-de-Marne

Sainte Catherine Institut du Cancer Avignon Provence, Avignon, Vaucluse

Centre Hospitalier Universitaire de Poitiers, Poitiers, Vienne

Universitaetsklinikum Freiburg, Freiburg, Baden-Württemberg

Thoraxklinik-Heidelberg gGmbH, Heidelberg, Baden-Württemberg

Universitaetsklinikum Tuebingen, Tübingen, Baden-Württemberg

Onkologiezentrum Donauwörth, Donauwörth, Bayern

Asklepios Fachkliniken München-Gauting, Gauting, Bayern

Klinikum Nürnberg Nord, Nürnberg, Bayern

Universitätsklinikum Münster - Albert Schweitzer Campus, Münster, Nordrhein-Westfalen

Krankenhaus Martha-Maria Halle-Dölau, Halle, Sachsen-Anhalt

LungenClinic Grosshansdorf, Grosshansdorf, Schleswig-Holstein

SRH Wald-Klinikum Gera, Gera, Thüringen

Evangelische Lungenklinik Berlin, Berlin, Not set

Charité Campus Virchow-Klinikum, Berlin, Not set

Helios Klinikum Emil von Behring Berlin-Zehlendorf, Berlin, Not set

Hämato-Onkologie Hamburg, Prof. Laack und Partner, Hamburg, Not set

University Hospital of Patras, Patras, Achaḯa

Agios Savvas Regional Cancer Hospital, Athens, Attikí

Errikos Dunant Hospital Center, Athens, Attikí

Sotiria Thoracic Diseases Hospital of Athens, Athens, Attikí

University General Hospital of Heraklion, Heraklion, Irakleío

European Interbalkan Medical Center, Thessaloniki, Thessaloníki

G. Papanikolaou General Hospital, Thessaloniki, Thessaloníki

Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét, Bács-Kiskun

Országos Korányi Pulmonológiai Intézet, Budapest, Pest

Farkasgyepui Tudogyogyintezet, Farkasgyepű, Veszprém

Országos Onkológiai Intézet, Budapest, Not set

Uzsoki Utcai Kórház, Budapest, Not set

Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi

KLES Dr. Prabhakar Kore Hospital & M.R.C, Belagave, Karnataka

SRV Hospitals, Bengaluru, Karnataka

Regional Cancer Centre - Thiruvananthapuram, Thiruvananthapuram, Kerala

Krishna Institute of Medical Sciences - Karad, Karad, Maharashtra

Kolhapur Cancer Centre Private Limited, Kolhāpur, Maharashtra

Tata Memorial Hospital, Mumbai, Maharashtra

HCG Manavata Cancer Centre, Nashik, Maharashtra

Grant Medical Foundation - Ruby Hall Clinic, Pune, Maharashtra

Sahyadri Super Speciality Hospital, Pune, Maharashtra

All India Institute of Medical Sciences, Bhubaneswar, Odisha

Ashwin Hospital, Coimbatore, Tamil Nadu

Nizam's Institute of Medical Sciences, Hyderabad, Telangana

Tata Memorial Centre - Homi Bhabha Cancer Hospital, Varanasi, Uttar Pradesh

Banaras Hindu University, Varanasi, Uttar Pradesh

Tata Medical Center, Kolkata, West Bengal

Postgraduate Institute of Medical Education & Research, Chandigarh, Not set

Jawaharlal Institute Of Postgraduate Medical Education And Research, Puducherry, Not set

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania

Fondazione Policlinico Universitario Agostino Gemelli, Roma, Lazio

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia

Istituto Nazionale Tumori Regina Elena, Rome, Roma

Policlinico "G. Rodolico", Catania, Sicilia

Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento, Verona, Veneto

IRCCS - AOU di Bologna, Bologna, Not set

Istituto Oncologico Veneto IRCCS, Padova, Not set

Ospedale di Circolo e Fondazione Macchi Varese, Varese, Not set

Aichi Cancer Center Hospital, Nagoya, Aichi

National Cancer Center Hospital East, Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime

Hokkaido University Hospital, Sapporo, Hokkaido

Himeji Medical Center, Himeji, Hyogo

Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa

Kanagawa cancer center, Yokohama, Kanagawa

Miyagi Cancer Center, Natori, Miyagi

Niigata Cancer Center Hospital, Niigata-shi, Niigata

Kansai Medical University Hospital, Hirakata, Osaka

Kindai University Hospital- Osakasayama Campus, Osakasayama, Osaka

National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Osaka

Tominaga Hospital, Nagaizumi-cho,Sunto-gun, Shizuoka

Tokyo Metropolitan Komagome Hospital, Bunkyō-Ku, Tokyo

Japanese Foundation for Cancer Research, Koto, Tokyo

Tottori University Hospital, Yonago, Tottori

National Hospital Organization Yamaguchi Ube Medical Center, Ube, Yamaguchi

National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set

Kyushu University Hospital, Fukuoka, Not set

University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Not set

Okayama University Hospital, Okayama, Not set

Wakayama Medical University Hospital, Wakayama, Not set

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]

Chonnam National University Hwasun Hospital, Hwasun, Jeonranamdo

National Cancer Center, Goyang-si, Kyǒnggi-do

The Catholic University Of Korea St. Vincent's Hospital, Suwon-si, Kyǒnggi-do

Pusan National University Yangsan Hospital, Yangsan, Kyǒngsangnam-do

Gangnam Severance Hospital, Gangnam-gu, Seoul-teukbyeolsi [Seoul]

Korea University Anam Hospital, Seoul, Seoul-teukbyeolsi [Seoul]

Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]

Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]

Korea University Guro Hospital, Seoul, Seoul-teukbyeolsi [Seoul]

Hanyang University Seoul Hospital, Seoul, Seoul-teukbyeolsi [Seoul]

Samsung Medical Center, Seoul, Seoul-teukbyeolsi

Kyungpook National University Chilgok Hospital, Daegu, Taegu-Kwangyǒkshi

Keimyung University Dongsan Hospital, Daegu, Taegu-Kwangyǒkshi

Health Pharma Professional Research S.A. de C.V:, Ciudad de México, Distrito Federal

Centro Onco-Hematológico Roma (COHR), Mexico City, Distrito Federal

Higiea Oncologia, Mexico City, Distrito Federal

Preparaciones Oncológicas S.C., León, Guanajuato

CIO - Centro de Inmuno-Oncología de Occidente, Guadalajara, Jalisco

PanAmerican Clinical Research - Guadalajara, Guadalajara, Jalisco

Actualidad Basada en la Investigación del Cáncer, Guadalajara, Jalisco

Renati Innovation, Guadalajara, Jalisco

Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo León

Avix Investigación Clinica, S.C., Monterrey, Nuevo León

Oncare - Unidad Valle, San Pedro Garza García, Nuevo León

Health Pharma Querétaro, Juriquilla, Querétaro

Centro de Investigacion Clinica de Oaxaca, Oaxaca, Not set

Clinica Integral Internacional de Oncología, Puebla, Not set

Arké SMO S.A de C.V, Veracruz, Not set

Medische Centrum Leeuwarden, Leeuwarden, Fryslân

Jeroen Bosch ziekenhuis, Den Bosch, Noord-Brabant

ETZ Elisabeth, Tilburg, Noord-Brabant

Medisch Spectrum Twente, Enschede, Overijssel

Leids Universitair Medisch Centrum, Leiden, Zuid-Holland

Erasmus Medisch Centrum, Rotterdam, Zuid-Holland

St. Antonius Ziekenhuis, locatie Utrecht, Utrecht, Not set

Akershus Universitetssykehus, Lørenskog, Akershus

Drammen Sykehus, Vestre Viken HF, Drammen, Buskerud

Haukeland Universitetssjukehus, Bergen, Hordaland

Sykehuset Innlandet HF Gjøvik, Gjøvik, Oppland

Stavanger Universitetssykehus, Stavanger, Rogaland

St. Olavs Hospital, Trondheim, Sør-Trøndelag

Oslo Universitetssykehus Ullevål, Oslo, Not set

MICS Centrum Medyczne Torun, Torun, Kujawsko-pomorskie

One Day Med, Szczecin, Zachodniopomorskie

Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej, Kielce, Świętokrzyskie

Champalimaud Foundation, Lisbon, Lisboa

Hospital Pulido Valente, Lisbon, Lisboa

Centro Hospitalar E Universitário De Coimbra, Coimbra, Not set

Hospital da Luz Lisboa, Lisboa, Not set

Centro Hospitalar do Porto - Hospital de Santo António, Porto, Not set

Hospital CUF Porto, Porto, Not set

Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set

Lotus-Med, Bucharest, Bucuresti

Institutul Oncologic, Cluj-Napoca, Cluj

Ovidius Clinical Hospital OCH, Ovidiu, Constanța

Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj

S C Oncocenter Oncologie Clinica S R L, Timișoara, Timiș

Cabinet Medical Oncomed, Timișoara, Timiș

Centrul medical Focus, București, Not set

Gral Medical Diagnostic Center, București, Not set

CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]

CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [

Hospital Universitari Son Espases, Palma De Mallorca, Balears [Baleares]

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]

Instituto Catalan de Oncologia - Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona [Barcelona]

Complejo Asistencial Universitario de León - Hospital de León, León, Castilla Y León

Hospital Universitari Dexeusa, Barcelona, Catalunya [Cataluña]

Hospital Jerez de la Frontera, Jerez De La Frontera, Cádiz

Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas

Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De

Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcon, Madrid

Complejo Hospitalario de Navarra, Pamplona, Navarra

Hospital Clinico de Valencia, Valencia, Valenciana, Comunitat

Hospital Infanta Cristina, Badajoz, Not set

Hospital Regional Universitario, Málaga, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Västmanlands Sjukhus Västerås, Västerås, Västmanlands Län [se-19]

CHUV (centre hospitalier universitaire vaudois), Lausanne, Vaud

Kantonsspital Winterthur, Winterthur, Not set

UniversitätsSpital Zürich, Zürich, Not set

Changhua Christian Hospital, Changhua County, Changhua

Hualien Tzu Chi Medical Center, Hualien City, Hualien

Chung Shan Medical University Hospital, Taichung City, Taichung

Chi Mei Hospital - Liouying Branch, Tainan City, Tainan

National Taiwan University Cancer Center (NTUCC), Taipei City, Taipei

National Taiwan University Hospital Yun-Lin Branch Dou-Liou Region, Douliu City, Yunlin

Buddhist Dalin Tzu Chi General Hospital, Chiayi, Not set

Kaohsiung Medical University Hospital, Kaohsiung, Not set

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung, Not set

Taichung Veterans General Hospital, Taichung, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Not set

Adana Medical Park Seyhan Hastanesi, Adana, Not set

Adana City Hospital, Adana, Not set

Ankara Etlik City Hospital, Ankara, Not set

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi, Ankara, Not set

Ankara City Hospital, Ankara, Not set

Akdeniz Universitesi Hastanesi, Antalya, Not set

Memorial Antalya Hospital, Antalya, Not set

Uludag Universitesi, Bursa, Not set

Dicle Üniversitesi, Diyarbakir, Not set

Bezmialem Vakf Üniversitesi, Istanbul, Not set

İ.A.Ü VM Medical Park Florya Hastanesi, Istanbul, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul, Not set

Ege Universitesi Hastanesi, Izmir, Not set

zmir Katip Çelebi Üniversitesi Atatürk Eitim Ve Aratrma Hastanesi, Izmir, Not set

Ondokuz Mayıs Universitesi, Samsun, Not set

Aberdeen Royal Infirmary, Aberdeen, Aberdeen City

Ninewells Hospital and Medical School, Dundee, Angus

Weston Park Hospital, Sheffield, England

Cheltenham General Hospital, Cheltenham, Gloucestershire

Mount Vernon Hospital, Northwood, Hillingdon

The Christie NHS Foundation Trust, Manchester, Withington

St James's University Hospital, Leeds, Not set

New Cross Hospital, Wolverhampton, Not set

Conditions: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Learn More ›

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006/KEYVIBE-006)

NCT05298423

Recruiting

This study is to evaluate the safety and efficacy of pembrolizumab/vibostolimab (MK-7684A) in combination with concurrent chemoradiotherapy (cCRT) followed by pembrolizumab/vibostolimab versus cCRT followed by durvalumab in participants with unresectable, locally advanced, stage III Non-small Cell Lung Cancer (NSCLC). The primary hypotheses are that pembrolizumab/vibostolimab with cCRT followed by pembrolizumab/vibostolimab is superior to cCRT followed by durvalumab with respect to the following... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

04/24/2024

Locations: VA Long Beach Healthcare System ( Site 2831), Long Beach, California +141 locations

VA Long Beach Healthcare System ( Site 2831), Long Beach, California

VA West Los Angeles Medical Center ( Site 2808), Los Angeles, California

Millennium Oncology Research Clinic ( Site 2801), Hollywood, Florida

Mid Florida Hematology and Oncology Center ( Site 2800), Orange City, Florida

University of Chicago Medical Center ( Site 2828), Chicago, Illinois

Franciscan St. Francis Health ( Site 2812), Indianapolis, Indiana

MFSMC-HJWCI ( Site 2804), Baltimore, Maryland

Boston Medical Center ( Site 2829), Boston, Massachusetts

University of Massachusetts Chan Medical School ( Site 2815), Worcester, Massachusetts

Cox Medical Center North-Cox Medical Center/Hulston Cancer Center/ Radiation Oncology ( Site 2837), Springfield, Missouri

Rutgers Cancer Institute of New Jersey ( Site 2805), New Brunswick, New Jersey

Icahn School of Medicine at Mount Sinai ( Site 2821), New York, New York

White Plains Hospital ( Site 2835), White Plains, New York

Kaiser Permanente Northwest-Central Interstate--Oncology ( Site 2816), Portland, Oregon

Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 2827), Lancaster, Pennsylvania

Thomas Jefferson University - Clinical Research Institute ( Site 2813), Philadelphia, Pennsylvania

Millennium Research & Clinical Development ( Site 2811), Houston, Texas

Central Texas Veterans health care-Oncology & Hematology ( Site 2819), Temple, Texas

MultiCare Health System ( Site 2817), Tacoma, Washington

Canberra Hospital ( Site 0010), Canberra, Australian Capital Territory

Icon Cancer Centre Hobart ( Site 0003), Hobart, Tasmania

Ballarat Health Services-Medical Oncology ( Site 0002), Ballarat Central, Victoria

Frankston Hospital-Oncology and Haematology ( Site 0009), Frankston, Victoria

St Vincent's Hospital-Oncology Clinical Trials ( Site 0005), Melbourne, Victoria

Hospital Nossa Senhora da Conceição ( Site 0111), Porto Alegre, Rio Grande Do Sul

Instituto de Educação, Pesquisa e Gestão em Saúde ( Site 0105), Rio de Janeiro, Not set

A. C. Camargo Cancer Center-CAPEC ( Site 0102), Sao Paulo, Not set

James Lind Centro de Investigación del Cáncer ( Site 0202), Temuco, Araucania

Biocenter ( Site 0208), Concepción, Biobio

FALP-UIDO ( Site 0205), Santiago, Region M. De Santiago

Centro de Oncología de Precisión ( Site 0209), Santiago, Region M. De Santiago

Bradfordhill ( Site 0200), Santiago, Region M. De Santiago

ONCOCENTRO APYS-ACEREY ( Site 0203), Viña del Mar, Valparaiso

Beijing Cancer hospital-intrathoratic deparmtment II ( Site 0328), Beijing, Beijing

Beijing Cancer hospital-Oncology Radiotherapy Department ( Site 0309), Beijing, Beijing

Beijing Peking Union Medical College Hospital-pneumology department ( Site 0300), Beijing, Beijing

Army Medical Center of People's Liberation Army-Oncology Department ( Site 0321), Chongqing, Chongqing

Fujian Medical University Union Hospital-1 Bingfanglou ( Site 0330), Fuzhou Fujian, Fujian

Fujian Provincial Cancer Hospital ( Site 0316), Fuzhou, Fujian

The First Affiliated hospital of Xiamen University-oncology ( Site 0317), Xiamen, Fujian

Southern Medical University Nanfang Hospital-Department of Oncology ( Site 0336), Guangzhou, Guangdong

Fourth Hospital of Hebei Medical University ( Site 0331), Shijiazhuang, Hebei

Henan Cancer Hospital ( Site 0333), Zhengzhou, Henan

Wuhan Union Hospital Cancer Center-Cancer Center ( Site 0315), Wuhan, Hubei

Hubei Cancer Hospital ( Site 0311), Wuhan, Hubei

Xiangya Hospital Central South University-Oncology department ( Site 0310), Changsha, Hunan

Hunan Cancer Hospital ( Site 0307), Changsha, Hunan

The Second Affiliated Hospital of Soochow University ( Site 0314), Suzhou, Jiangsu

Affiliated Hospital of Jiangsu University ( Site 0305), Zhenjiang, Jiangsu

Jilin Cancer Hospital-oncology department ( Site 0319), Changchun, Jilin

Shandong Provincial Hospital ( Site 0326), Jinan, Shandong

Qingdao Central Hospital-Endocrinology ( Site 0332), Qingdao, Shandong

Shanghai Chest Hospital-Radiotherapy Department ( Site 0306), Shanghai, Shanghai

Fudan University Shanghai Cancer Center ( Site 0304), Shanghai, Shanghai

Shanghai Pulmonary Hospital-Radiotherapy department ( Site 0335), Shanghai, Shanghai

Shanxi Cancer Hospital-Pulmonology ( Site 0322), Taiyuan, Shanxi

West China Hospital of Sichuan University ( Site 0324), Cheng Du, Sichuan

Tianjin Medical University Cancer Institute and Hospital-radiotherapy ( Site 0329), Tianjin, Tianjin

Hangzhou Cancer Hospital-Medical Oncology ( Site 0302), Hangzhou, Zhejiang

The Second Affiliated hospital of Zhejiang University school of medicine ( Site 0301), Hangzhou, Zhejiang

Zhejiang Cancer Hospital ( Site 0308), Hangzhou, Zhejiang

CIMCA ( Site 0501), San José, San Jose

PROCLINICAL Pharma ( Site 0504), San José, San Jose

Hospital Metropolitano - Sede Lindora ( Site 0503), Santa Ana, San Jose

Instituto de Oncologia ( Site 3003), Santo Domingo, Distrito Nacional

Onconet ( Site 3002), Distrito Nacional, Santo Domingo

Klinikum Chemnitz-Klinik für Innere Medizin IV ( Site 0607), Chemnitz, Sachsen

LungenClinic Grosshansdorf-Onkologie ( Site 0602), Grosshansdorf, Schleswig-Holstein

Universitaetsklinikum Schleswig-Holstein Campus Kiel-Medizinische Klinik II, Hämatologie und Onkolo, Kiel, Schleswig-Holstein

Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 0603, Berlin, Not set

Errikos Dunant Hospital Center-Second Department of Oncology and Clinical Trials Unit ( Site 0703), Athens, Attiki

Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 0706), Athens, Attiki

Sotiria Thoracic Diseases Hospital of Athens ( Site 0704), Athens, Attiki

Metropolitan Hospital ( Site 0702), Athens, Attiki

General Oncology Hospital of Kifissia "Agioi Anargiroi"-2nd Department of Medical Oncology ( Site 07, Nea Kifissia, Attiki

University General Hospital of Heraklion-Internal Medicine-Oncology ( Site 0700), Heraklion, Irakleio

European Interbalkan Medical Center ( Site 0701), Thessaloniki, Not set

Private Practice- Dr. Rixci Augusto Lenin Ramírez ( Site 0802), Ciudad de Guatemala, Not set

Centro Regional de Sub Especialidades Médicas SA ( Site 0801), Quetzaltenango, Not set

Centro Medico Integral De Cancerología (CEMIC) ( Site 0805), Quetzaltenango, Not set

Rambam Health Care Campus-Oncology ( Site 1001), Haifa, Not set

Shaare Zedek Medical Center ( Site 1003), Jerusalem, Not set

Rabin Medical Center ( Site 1004), Petah Tikva, Not set

Sheba Medical Center-ONCOLOGY ( Site 1000), Ramat Gan, Not set

Sourasky Medical Center ( Site 1002), Tel Aviv, Not set

Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia medica Toraco-Polmonare ( Site 1107), Napoli, Campania

Policlinico Universitario Campus Bio-Medico-Radiation Oncology ( Site 1101), Roma, Lazio

Ospedale San Raffaele ( Site 1104), Milano, Lombardia

Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1100), Milan, Lombardia

Ospedale San Gerardo-ASST Monza-Oncologia ( Site 1102), Monza, Lombardia

Fondazione IRCCS Policlinico San Matteo ( Site 1103), Pavia, Lombardia

Azienda Ospedaliera Spedali Civili di Brescia ( Site 1105), Brescia, Not set

National Hospital Organization Shikoku Cancer Center ( Site 1211), Matsuyama, Ehime

Kurume University Hospital ( Site 1212), Kurume, Fukuoka

Kobe Minimally Invasive Cancer Center ( Site 1210), Kobe, Hyogo

Kanagawa cancer center ( Site 1204), Yokohama, Kanagawa

Miyagi Cancer Center ( Site 1200), Natori, Miyagi

Sendai Kousei Hospital ( Site 1213), Sendai, Miyagi

Niigata Cancer Center Hospital ( Site 1205), Niigata-shi, Niigata

Kansai Medical University Hospital ( Site 1207), Hirakata, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 1208), Takatsuki, Osaka

Saitama Prefectural Cancer Center ( Site 1201), Ina-machi, Saitama

Japanese Foundation for Cancer Research ( Site 1202), Koto, Tokyo

Showa University Hospital ( Site 1203), Shinagawa, Tokyo

Osaka International Cancer Institute ( Site 1209), Osaka, Not set

Chungbuk National University Hospital-Internal medicine ( Site 2400), Cheongju-si, Chungbuk

The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 2401), Suwon-si, Kyonggi-do

Ajou University Hospital-Hematology-Oncology ( Site 2402), Suwon-si, Kyonggi-do

Severance Hospital, Yonsei University Health System-Lung Cancer Center ( Site 2403), Seoul, Not set

University Malaya Medical Centre-Clinical Oncology ( Site 1402), Lembah Pantai, Kuala Lumpur

Hospital Pulau Pinang ( Site 1400), George Town, Pulau Pinang

Hospital Kuala Lumpur-Radiotherapy and Oncology ( Site 1401), Kuala Lumpur, Not set

Arké SMO S.A. de C.V. ( Site 1504), Mexico, Distrito Federal

Actualidad Basada en la Investigación del Cáncer-Lung Cancer ( Site 1505), Guadalajara, Jalisco

Centro Oncologico de Chihuahua-Unidad de Investigacion Clinica ( Site 1507), Chihuahua, Not set

Centro de Investigacion Clinica de Oaxaca ( Site 1501), Oaxaca, Not set

Hospital CUF Descobertas ( Site 2006), Lisbon, Lisboa

Centro Hospitalar do Porto - Hospital de Santo António ( Site 2004), Porto, Not set

Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2001), Porto, Not set

Centrul Medical Medicover Victoria ( Site 2106), Bucharest, Bucuresti

Amethyst Radiotherapy Center ( Site 2102), Florești, Cluj

Centrul de Oncologie "Sfântul Nectarie" ( Site 2100), Craiova, Dolj

Radiology Therapeutic Center ( Site 2108), Otopeni, Ilfov

Cabinet Medical Oncomed ( Site 2101), Timișoara, Timis

CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 2304), Port Elizabeth, Eastern Cape

Wilgers Oncology Centre ( Site 2301), Pretoria, Gauteng

The Oncology Centre ( Site 2300), Durban, Kwazulu-Natal

Abraham Oncology ( Site 2303), Richards Bay, Kwazulu-Natal

Cape Town Oncology Trials ( Site 2306), Cape Town, Western Cape

HOSPITAL CLÍNIC DE BARCELONA-ICHMO- Clinic Institut of Haematological and Oncological diseases ( Sit, Barcelona, Cataluna

CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 2502), Santiago de Compostela, La Coruna

HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2504), Pozuelo de Alarcon, Madrid, Comunidad De

Hospital Universitari Vall d'Hebron ( Site 2501), Barcelona, Not set

Medipol Mega Universite Hastanesi-oncology ( Site 2611), Stanbul, Istanbul

Ege University Medicine of Faculty-Chest Diseases Department ( Site 2603), Bornova, Izmir

I.E.U. Medical Point Hastanesi-Oncology ( Site 2612), Izmir, Karsiyaka, Izmir

Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 2607), Adana, Not set

Ankara Gülhane Eitim ve Aratrma Hastanesi-Oncology ( Site 2602), Ankara, Not set

Hacettepe Universitesi-oncology hospital ( Site 2605), Ankara, Not set

Memorial Ankara Hastanesi-Medical Oncology ( Site 2609), Ankara, Not set

Ankara City Hospital-Medical Oncology ( Site 2601), Ankara, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2610), Istanbul, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

NCT04165798

Recruiting

This study is referred to as the "umbrella master protocol" for pembrolizumab (MK-3475) in the treatment of non-small cell lung cancer (NSCLC). This pembrolizumab NSCLC umbrella master protocol uses a platform design and consists of this master screening study and three substudies. Each substudy will enroll a different population of NSCLC participants. The goal of this umbrella master protocol is to screen potential participants with NSCLC for enrollment into 1 of 4 substudies. Participants mus... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

04/23/2024

Locations: Banner MD Anderson Cancer Center ( Site 0001), Gilbert, Arizona +38 locations

Banner MD Anderson Cancer Center ( Site 0001), Gilbert, Arizona

City of Hope ( Site 0014), Duarte, California

UCSF Medical Center at Mission Bay ( Site 0007), San Francisco, California

Georgetown University ( Site 0036), Washington, District of Columbia

University of Kentucky Markey Cancer Center ( Site 0019), Lexington, Kentucky

MedStar Franklin Square Medical Center ( Site 0033), Baltimore, Maryland

Massachusetts General Hospital ( Site 0003), Boston, Massachusetts

Dana Farber Cancer Institute ( Site 0002), Boston, Massachusetts

Oncology Hematology West, PC DBA Nebraska Cancer Specialists ( Site 0031), Omaha, Nebraska

Dartmouth Hitchcock Medical Center ( Site 0016), Lebanon, New Hampshire

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0037), Hackensack, New Jersey

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0034), New York, New York

Sanford Fargo Medical Center ( Site 0039), Fargo, North Dakota

Cleveland Clinic ( Site 0006), Cleveland, Ohio

Ohio State University Comprehensive Cancer Center ( Site 0015), Columbus, Ohio

Abramson Cancer Center of the University of Pennsylvania ( Site 0010), Philadelphia, Pennsylvania

Sanford Cancer Center ( Site 0038), Sioux Falls, South Dakota

The University of Texas MD Anderson Cancer Center ( Site 0009), Houston, Texas

Petz Aladar Megyei Oktato Korhaz ( Site 0062), Gyor, Gyor-Moson-Sopron

Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 0061), Szolnok, Jasz-Nagykun-Szolnok

Orszagos Koranyi Pulmonologiai Intezet ( Site 0060), Budapest, Not set

Soroka Medical Center ( Site 0072), Beer-Sheva, Not set

Rambam Health Care Campus-Oncology ( Site 0076), Haifa, Not set

Shaare Zedek Medical Center ( Site 0075), Jerusalem, Not set

Meir Medical Center ( Site 0071), Kfar-Saba, Not set

Rabin Medical Center ( Site 0074), Petah Tikva, Not set

Chaim Sheba Medical Center ( Site 0070), Ramat Gan, Not set

Sourasky Medical Center ( Site 0077), Tel Aviv, Not set

Azienda Ospedaliera Universitaria Careggi ( Site 0173), Florence, Firenze

Policlinico Gemelli di Roma ( Site 0174), Roma, Lazio

IRCCS Ospedale San Raffaele ( Site 0171), Milano, Not set

Seoul National University Bundang Hospital ( Site 0081), Seongnam-si, Kyonggi-do

Severance Hospital ( Site 0080), Seoul, Not set

Samsung Medical Center ( Site 0082), Seoul, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier, Warszawa, Mazowieckie

Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150), Gdańsk, Pomorskie

Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0152), Koszalin, Zachodniopomorskie

ICO L Hospitalet ( Site 0090), Hospitalet de Llobregat, Barcelona

Hospital Universitario Quiron Madrid ( Site 0091), Pozuelo de Alarcon, Madrid

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer

NCT05488314

Recruiting

The purpose of this study is to identify the recommended Phase 2 combination dose (RP2CD[s]) of the amivantamab and capmatinib combination therapy in participants with non-small cell lung cancer (NSCLC) in Phase 1 (combination dose selection), and to evaluate the antitumor effect of the amivantamab and capmatinib combination therapy in mesenchymal-epithelial transition (MET) exon 14 skipping mutation and MET amplified NSCLC, when administered at the selected RP2CD(s) in Phase 2 (expansion).

Gender:

All

Ages:

18 years and above

Trial Updated:

04/23/2024

Locations: University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama +76 locations

University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama

The Oncology Institute of Hope and Innovation, Cerritos, California

UCLA, Los Angeles, California

Montefiore Einstein Center for Cancer Care, Bronx, New York

Virginia Cancer Specialists, Fairfax, Virginia

PERSONAL Oncologia de Precisao e Personalizada, Belo Horizonte, Not set

CIONC Centro Integrado de Oncologia de Curitiba, Curitiba, Not set

UPCO Unidade de Pesquisa Clinica em Oncologia, Pelotas, Not set

Uniao Brasileira de Educaçao e Assistencia-Hospital Sao Lucas da PUCRS, Porto Alegre, Not set

Oncoclinicas Rio de Janeiro S A, Rio de Janeiro, Not set

Instituto D Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Not set

Nucleo de Oncologia da Bahia, Salvador, Not set

Fundacao Antonio Prudente A C Camargo Cancer Center, Sao Paulo, Not set

Sociedade Beneficente de Senhoras - Hospital Sírio Libanês, São Paulo, Not set

The Ottawa Hospital Research Institute, Ottawa, Ontario

University Health Network (UHN) Princess Margaret Cancer Centre, Toronto, Ontario

Sichuan Cancer Hospital, Chengdu, Not set

West China Hospital Sichuan University, Chengdu, Not set

Chongqing University Cancer Hospital, Chongqing, Not set

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Not set

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Not set

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Not set

Huizhou Municipal Central Hospital, Huizhou, Not set

Fudan University Shanghai Cancer Center, Shanghai, Not set

Shanghai Pulmonary Hospital, Shanghai, Not set

Shengjing Hospital of China Medical University, Shenyang, Not set

The First Affiliated Hospital of Xian Jiaotong University, Xi'An, Not set

Yantai Yuhuangding Hospital, Yantai, Not set

Henan Cancer Hospital, Zhengzhou, Not set

Institute Coeur Poumon, Lille, Not set

CHU de la Timone, Marseille, Not set

Institut de cancerologie de l'ouest, Saint-Herblain Cedex, Not set

Nouvel Hopital Civil - CHU Strasbourg, Strasbourg cedex, Not set

Charite Universitaetsmedizin Berlin, Berlin, Not set

Klinikum Chemnitz gGmbH, Chemnitz, Not set

Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Not set

Universitaetsklinikum Essen, Essen, Not set

Universitaetsklinikum Koeln, Koeln, Not set

Universitaetsklinikum Muenster, Muenster, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Not set

ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set

Fondazione G Pascale Istituto Nazionale Tumori IRCCS, Napoli, Not set

Istituto Oncologico Veneto - IRCCS, Padova, Not set

Ospedale S. Maria Delle Croci, Ravenna, Not set

Istituto Nazionale Tumori Regina Elena, Rome, Not set

National Hospital Organization Nagoya Medical Center, Nagoya-shi, Not set

Shizuoka Cancer Center, Sunto-gun, Not set

The Cancer Institute Hospital of JFCR, Tokyo, Not set

Chungbuk National University Hospital, Cheongju-si, Not set

National Cancer Center, Goyang-Si, Not set

Gachon University Gil Hospital, Incheon, Not set

Chonnam National University Hwasun Hospital, Jeollanam-do, Not set

Seoul National University Bundang Hospital, Seongnam, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System, Seoul, Not set

Asan Medical Center, Seoul, Not set

Uniwersyteckie Centrum Kliniczne, Gdansk, Not set

INSTYTUT GENETYKI I IMMUNOLOGII GENIM Sp z o o, Lublin, Not set

Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warszawa, Not set

Hosp. Univ. A Coruna, A Coruna, Not set

Hosp. Gral. Univ. de Alicante, Alicante, Not set

Hosp. Del Mar, Barcelona, Not set

Hosp. Univ. Quiron Dexeus, Barcelona, Not set

Hosp. Univ. Vall D Hebron, Barcelona, Not set

Hosp. Clinic de Barcelona, Barcelona, Not set

Hosp. Univ. Fund. Jimenez Diaz, Madrid, Not set

Hosp. Univ. 12 de Octubre, Madrid, Not set

Hosp. Univ. La Paz, Madrid, Not set

Hosp. Virgen Macarena, Sevilla, Not set

Hosp. Clinico Univ. de Valencia, Valencia, Not set

Gazi University Hospital, Ankara, Not set

Ankara Bilkent City Hospital, Ankara, Not set

Ankara Bilkent City Hospital, Cankaya, Not set

University College London Hospitals Nhs Foundation Trust, London, Not set

Imperial College London and Imperial College Healthcare NHS Trust, London, Not set

Sir Bobby Robson Cancer Trials Research Centre, Newcastle upon Tyne, Not set

Royal Marsden Hospital, Sutton, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

1 - 12 of 47